Close -

What Happens to the Brain With Alzheimer’s Disease?

What Happens to the Brain With Alzheimer’s Disease?
Categories:
Date:
December 28, 2021

As human beings age, certain changes happen to the brain, as with any part of the body. For a person with Alzheimer’s disease, though, these changes manifest with much more noticeable symptoms. Of course, there are many more obvious Alzheimer symptoms, like a decrease in executive function, loss of memory, and flattening of affect. Through the stages of Alzheimer’s, there are other brutal changes happening on a cellular level.

The Aging Brain

img

In the typical brain, aging leads the brain to shrink noticeably. At the same time, it’s important to note that this shrinkage does not, in most instances, lead to widespread damage or loss of neurons. With Alzheimer’s, however, that is very much the case. Alzheimer’s disease involves significant changes on the molecular and cellular levels, which scientists can examine in post-mortem tissue with the help of a microscope. While they don’t currently have a known cause for Alzheimer’s, the ever-increasing understanding of Alzheimer’s disease and dementia contributes to recognizing the cause and even potentially curing these potent forms of memory loss.

Destruction of Neurons

The widespread disruption, damage, and death of neurons and connections between neurons in the brain are hallmark signs of Alzheimer’s disease, initially in areas of the brain like the entorhinal cortex and hippocampus, which are involved in memory. As time goes on and the disease progresses, the same destruction will reach the cerebral cortex and other parts of the brain, impacting language, social abilities, reasoning, and other vital human traits. Eventually, Alzheimer’s patients are unable to live independently and may need a constant caregiver through the depths of this terminal disease.

Clumping Beta-Amyloid Proteins

img

Amyloid plaques are one such effect of Alzheimer’s on the brain. The beta-amyloid protein is formed by the breakdown of an amyloid precursor protein, a larger protein that leads to these toxic molecular forms. These proteins appear at abnormally high levels in the brain of a person with Alzheimer’s disease and clump together to form amyloid plaques. Through the stages of Alzheimer’s, these beta-amyloid clumps collect between neurons and disrupt cell function in various ways.

Accumulation of Tau

Like amyloid plaques, a protein known as tau accumulates at abnormal levels inside neurons, creating what are known as neurofibrillary tangles. While tau stabilizes microtubules (structures that guide nutrients from the cell body) in a healthy brain, a brain with Alzheimer’s disease finds the same tau proteins sticking to the same kinds of molecules, forming these disastrous tangles. These block the synaptic communication between neurons. In fact, some experts suggest that the changes within an Alzheimer’s-afflicted brain may occur, at least in part, due to the interactions of both beta-amyloid and tau at abnormal levels.

Chronic Inflammation

img

Within the brain of someone with Alzheimer’s disease, chronic inflammation is another serious issue. Current evidence suggests that this inflammation is caused by the buildup of microglia, a type of glial cell that destroys debris, such as beta-amyloid plaques within the brain. Alzheimer’s causes these microglia to fail at cleaning away debris, though experts have not yet identified why this failure occurs. In addition, microglia and astrocytes, another glial cell, harm neurons and cause chronic inflammation within the Alzheimer’s brain.

Brain Atrophy

Through the stages of Alzheimer’s disease, neuron connections break as various regions of the brain shrink. With neurons becoming injured and dying, the terminal phase of Alzheimer’s disease leads to a widespread process known as brain atrophy, in which the brain loses significant volume. The symptoms of brain atrophy include memory loss, seizures, and aphasias, and while there are other causes, at least 60 percent of brain atrophy cases are attributed to Alzheimer’s disease or dementia.

Written By
VP, Director of Client Engagement

Explore more articles

Get In Touch

Want to learn more about us, or offer tips and suggestions? Let’s get in touch!

Justin Henderson
VP, Director of Client Engagement

Known as a purveyor of big ideas, Carrie has fueled visibility and growth for brands from leadership seats at a roster of highly regarded agencies. Her innovative thinking and strategic mindset distinguished her career at Publicis.Sapient/Rosetta, OMNICOM Group’s GO! Experience Design, MullenLowe Group (a subsidiary of the Interpublic Group of Companies) and Brownstein Group.

In more than 20 years of shaping strategy and seeking the aha moment, Carrie has worked with brands from Nabisco to Samsung Appliances. She spearheaded Frank About Women, a marketing-to-women consultancy of MullenLowe. This initiative offered a proprietary approach to counseling global companies on gender-savvy brand strategies and revitalization programs.

Carrie guides our agency’s Client Engagement team, working closely with Connections, Creative, Delivery and Insights leaders to develop and implement inspired marketing solutions that spring from big ideas and evidence a deep appreciation for better performing work. Her comprehensive knowledge and killer instincts translate to creative solutions that earn awards and results as well as the trust of her clients.

Recent Articles